Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/ Refractory Large B-Cell Lymphomas

被引：0
|
作者：
Balitsky, Amaris K. [1 ,2 ]
Pond, Gregory R. [2 ]
Fraser, Graeme [1 ,2 ]
Kouroukis, Tom [1 ,2 ]
Foley, Stephen Ronan [1 ,2 ]
机构：
[1] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada
[2] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165674
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8036 / 8037
页数：2
相关论文
共 50 条
  • [31] Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
    Schuster, Stephen J.
    Svoboda, Jakub
    Chong, Elise A.
    Nasta, Sunita D.
    Mato, Anthony R.
    Anak, Ozlem
    Brogdon, Jennifer L.
    Pruteanu-Malinici, Iulian
    Bhoj, Vijay
    Landsburg, Daniel
    Wasik, Mariusz
    Levine, Bruce L.
    Lacey, Simon F.
    Melenhorst, Jan J.
    Porter, David L.
    June, Carl H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26): : 2545 - 2554
  • [32] Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas
    Chong, Elise A.
    Penuel, Elicia
    Napier, Ellen B.
    Lundberg, Rachel K.
    Budde, Lihua E.
    Shadman, Mazyar
    Matasar, Matthew J.
    Bartlett, Nancy L.
    Flinn, Ian W.
    Bosch, Francesc
    Fay, Keith
    Goy, Andre
    Kumar, Anita
    Nastoupil, Loretta J.
    Wei, Michael C.
    Wu, Mei
    Yin, Shen
    Fraietta, Joseph A.
    Chong, Emeline R.
    Schuster, Stephen J.
    BLOOD ADVANCES, 2025, 9 (04) : 696 - 703
  • [33] The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
    Lutfi, Forat
    Kansagra, Ankit
    Ali, Moaath Mustafa
    Bukhari, Ali
    Siglin, Jonathan
    Yan, Jingsheng
    Samanta, Santanu
    Holtzman, Noa G.
    Gottlieb, David
    Kim, Dong Won
    Lee, Seung-Tae
    Kocoglu, Mehmet Hakan
    Yared, Jean A.
    Hardy, Nancy M.
    Molitoris, Jason
    Mohindra, Pranshu
    Rapoport, Aaron P.
    Dahiya, Saurabh
    BLOOD, 2020, 136
  • [34] Response to Mosunetuzumab in Patients with B-Cell Lymphomas Relapsed or Refractory after CAR-T Cell Therapy Is Associated with Changes in Lymphocyte Counts
    Chong, Elise A.
    Penuel, Elicia
    Bartlett, Nancy L.
    Bosch, Francesc
    Budde, L. Elizabeth
    Fay, Keith
    Flinn, Ian W.
    Goy, Andre
    Kumar, Anita
    Lundberg, Rachel
    Napier, Ellen B.
    Nastoupil, Loretta J.
    Shadman, Mazyar
    Wei, Michael C.
    Wu, Mei
    Yin, Shen
    Chong, Emeline R.
    Schuster, Stephen J.
    BLOOD, 2023, 142
  • [35] Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma
    Lyman, Gary H.
    Nguyen, Andy
    Snyder, Sophie
    Gitlin, Matthew
    Chung, Karen C.
    JAMA NETWORK OPEN, 2020, 3 (04) : E202072
  • [36] Financial toxicity among chimeric antigen receptor T-cell therapy (CAR-T) patients
    Crowder, Sylvia
    Hoogland, Aasha
    Quast, Troy
    Turner, Kea
    Irizarry-Arroyo, Nathaly
    Rodriguez, Yvelise
    Logue, Jennifer
    Locke, Frederick
    Jim, Heather
    PSYCHO-ONCOLOGY, 2021, 30 : 37 - 37
  • [37] Characterization of Infections After Chimeric Antigen Receptor T-Cell Therapy in Patients With Large B-Cell Lymphoma
    Pernas, Berta
    Iacoboni, Gloria
    Los-Arcos, Ibai
    Catala, Eva
    Carpio, Cecilia
    Barba, Pere
    Ruiz-Camps, Isabel
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 196 - 196
  • [38] TP53 and CD19-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma
    Shouval, Roni
    Tomas, Ana Alarcon
    Fein, Joshua A.
    Flynn, Jessica
    Markovits, Ettai
    Mayer, Shimrit
    Afuye, Aishat Olaide
    Alperovich, Anna
    Anagnostou, Theodora
    Batlevi, Connie Lee
    Dahi, Parastoo B.
    Devlin, Sean M.
    Fingrut, Warren
    Giralt, Sergio A.
    Lin, Richard J.
    Salles, Gilles
    Sauter, Craig S.
    Scordo, Michael
    Shah, Gunjan L.
    Shah, Nishi
    Shouval, Ruth Scherz
    van den Brink, Marcel
    Perales, Miguel-Angel
    Palomba, Maria Lia
    BLOOD, 2021, 138
  • [39] Safety and Feasibility of Chimeric Antigen Receptor T Cell Therapy after Allogeneic Stem Cell Therapy in Relapsed/Refractory B Cell Lymphomas
    Jain, Tania
    Sauter, Craig S.
    Shah, Gunjan L.
    Maloy, Molly A.
    Chan, Jason
    Scordo, Michael
    Avecilla, Scott T.
    Batlevi, Yakup
    Dahi, Parastoo B.
    Batlevi, Connie W.
    Palomba, M. Lia
    Giralt, Sergio A.
    Perales, Miguel-Angel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [40] Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: A case report
    Chen, Hsin-Hui
    Kuo, Cheng-Yi
    Ho, Ching-Liang
    Chen, Yeu-Chin
    MEDICINE, 2023, 102 (41) : E35432
12345